Archive - February 2018
Speedy EU review for Shire’s lanadelumab
A Modest Proposal Redux
Roche/Chugai’s Hemlibra wins green light for bleeding disorder
Kindred Healthcare’s bottom line hit by hospital, rehab site closures
California hospital websites offered dashboard to share patient safety data
Stem cell therapy offers hope for spinal cord injuries
AstraZeneca spins out new firm Viela Bio
FDA refuses to review Celgene’s ozanimod in multiple sclerosis
